NYSE:RL • US7512121010
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RALPH LAUREN CORP (RL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-06 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-06 | BTIG | Maintains | Buy -> Buy |
| 2026-02-06 | UBS | Maintains | Buy -> Buy |
| 2026-02-06 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2026-02-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-06 | Jefferies | Maintains | Buy -> Buy |
| 2026-02-05 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2026-02-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-30 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2026-01-28 | UBS | Maintains | Buy -> Buy |
| 2026-01-15 | Argus Research | Maintains | Buy -> Buy |
| 2026-01-08 | UBS | Maintains | Buy -> Buy |
| 2025-12-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-12 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-10 | Guggenheim | Initiate | Neutral |
| 2025-12-03 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-07 | UBS | Maintains | Buy -> Buy |
| 2025-11-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-11-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-03 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-30 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-10-23 | UBS | Maintains | Buy -> Buy |
| 2025-10-23 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-15 | BTIG | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.444B 3.62% | 6.631B 2.91% | 7.079B 6.75% | 8.203B 15.88% | 8.676B 5.77% | 9.085B 4.71% | 8.979B -1.17% | 9.203B 2.49% | 9.436B 2.53% | 9.679B 2.58% | 9.931B 2.60% | |
| EBITDA YoY % growth | 990.7M -5.94% | 1.055B 6.52% | 1.21B 14.61% | 1.544B 27.66% | 1.692B 9.59% | 1.798B 6.26% | 1.761B -2.06% | 1.788B 1.53% | 1.845B 3.19% | 1.903B 3.14% | 1.965B 3.26% | |
| EBIT YoY % growth | 770.2M -6.48% | 826.3M 7.28% | 989.9M 19.80% | 1.289B 30.22% | 1.406B 9.08% | 1.511B 7.47% | 1.384B -8.41% | 1.402B 1.30% | 1.449B 3.35% | 1.497B 3.31% | 1.548B 3.41% | |
| Operating Margin | 11.95% | 12.46% | 13.98% | 15.71% | 16.21% | 16.63% | 15.41% | 15.23% | 15.36% | 15.47% | 15.59% | |
| EPS YoY % growth | 8.36 0.24% | 10.32 23.44% | 12.33 19.48% | 15.98 29.61% | 17.60 10.13% | 19.74 12.15% | 18.98 -3.83% | 20.04 5.59% | 22.33 11.41% | 24.02 7.56% | 25.86 7.68% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.54 12.02% | 4.17 10.63% | 4.07 7.40% | 6.61 6.26% | 2.55 0.18% | 4.67 11.87% | 4.27 5.01% | 6.96 5.35% | 3.14 23.32% |
| Revenue Q2Q % growth | 1.891B 11.41% | 1.889B 9.88% | 2.151B 6.98% | 2.503B 4.03% | 1.912B 1.11% | 1.951B 3.28% | 2.276B 5.81% | 2.638B 5.39% | 2.011B 5.18% |
| EBITDA Q2Q % growth | 260.83M -33.87% | 387.65M 11.27% | 378.34M -4.34% | 594.08M -12.03% | 260.02M -0.31% | 402.73M 3.89% | 414.06M 9.44% | 615.94M 3.68% | 285.31M 9.73% |
| EBIT Q2Q % growth | 197.15M 12.79% | 322.37M 10.06% | 307.1M 8.52% | 509.33M 1.24% | 188.79M -4.24% | 341.96M 6.08% | 351.23M 14.37% | 553.11M 8.60% | 224.54M 18.94% |
All data in USD
28 analysts have analysed RL and the average price target is 409.61 USD. This implies a price increase of 20.85% is expected in the next year compared to the current price of 338.95.
RALPH LAUREN CORP (RL) will report earnings on 2026-05-20, after the market close.
The consensus EPS estimate for the next earnings of RALPH LAUREN CORP (RL) is 2.54 USD and the consensus revenue estimate is 1.89B USD.
The consensus rating for RALPH LAUREN CORP (RL) is 82.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.